Am J Ther 2022 May-Jun 01;29(3):e305-e321. Epub 2022 Apr 1.
Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Rockford, IL.
Background: Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection (PASC), or long-COVID, are signs and symptoms that persist after the acute phase of Coronavirus disease 2019 infection has passed. PASC is newly recognized, and research is ongoing to answer questions about pathology, symptoms, diagnosis, and optimal treatment.
Areas Of Uncertainty: Use of pharmacologic treatment for symptoms of PASC is currently evolving. Read More